Macrophage-derived HB-EGF activates EGFR signaling to impair atherogenic macrophage–vascular smooth muscle cell crosstalk in ASCVD

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis: molecular mechanisms and therapeutic targets Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology